It not only successfully regulates blood sugar levels [1] but also reduces the appetite and, thereby, the weight of patients [2], especially in individuals with obesity and type 2 diabetes mellitus (T2DM)
255 A randomized controlled trial in 320 NASH patients found 59% of those who received 72 weeks of treatment with subcutaneous injections of the GLP-1 RA semaglutide (Ozempic or Wegovy) and 17% of those receiving placebo experienced resolution of biopsy-confirmed NASH, although changes in fibrosis were not significantly different between groups
Strict timing rules can make adherence harder
Pakpahan, C., Agustinus, A., & Darmadi, D.(2021, May 22)
At Family Weight & Wellness Clinic, we use FDA-approved weight loss medications like Semaglutide and Tirzepatide, along with tools like peptide therapy and B12 injections, to support your journey to optimal weight and health
Actually, we've had patients lose over 100 pounds on both medications